We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current Z1TS34 market cap is 49.03B. The company's latest EPS is USD 2.9173 and P/E is 55.28.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.21B | 2.19B | 2.36B | 2.39B | 2.32B |
| Operating Income | 683M | 797M | 853M | 915M | 759M |
| Net Income | 525M | 599M | 624M | 682M | 581M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.68B | 7.78B | 8.08B | 8.54B | 9.26B |
| Operating Income | 2.22B | 2.73B | 2.88B | 2.98B | 3.32B |
| Net Income | 1.64B | 2.04B | 2.11B | 2.34B | 2.49B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.29B | 14.35B | 14.17B | 14.36B | 14.24B |
| Total Liabilities | 9.3B | 9.3B | 9.21B | 9.12B | 9.47B |
| Total Equity | 4.99B | 5.05B | 4.96B | 5.23B | 4.77B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.61B | 13.9B | 14.93B | 14.29B | 14.24B |
| Total Liabilities | 9.84B | 9.36B | 10.52B | 9.3B | 9.47B |
| Total Equity | 3.77B | 4.54B | 4.4B | 4.99B | 4.77B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.35B | 595M | 1.1B | 2.05B | 2.95B |
| Investing | -777M | -131M | -263M | -441M | -315M |
| Financing | -3.11B | -524M | -1.29B | -1.92B | -2.66B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.13B | 2.21B | 1.91B | 2.35B | 2.95B |
| Investing | -572M | -458M | -883M | -777M | -315M |
| Financing | 123M | -1.86B | -904M | -3.11B | -2.66B |
| Market Cap | 49.03B |
| Price to Earnings Ratio | 55.28 |
| Price to Sales Ratio | 14.85 |
| Price to Cash Ratio | 69.16 |
| Price to Book Ratio | 28.81 |
| Dividend Yield | 0.88% |
| Shares Outstanding | 852.15M |
| Average Volume (1 week) | 2.03k |
| Average Volume (1 Month) | 2.39k |
| 52 Week Change | 3.92% |
| 52 Week High | 70.00 |
| 52 Week Low | 47.10 |
| Spread (Intraday) | 4.56 (7.59%) |
| Company Name | Zoetis Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.zoetis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
